UnCRMPing Nav1.7 to treat trigeminal neuropathic pain.

No abstract is available for this paper.

• Publication year

  2023

• Venue

  Pain

• Publication date

  2023-09-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/j.pain.0000000000003054PMID 37751533
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intranasal CRMP2-Ubc9 inhibitor regulates NaV1.7 to alleviate trigeminal neuropathic pain.

  2023cited by this paper
• Diagnosis and treatment of trigeminal neuralgia: consensus statement from the Spanish Society of Neurology's Headache Study Group.

  2023cited by this paper
• Electrophysiological characterization of a CaV3.1 calcium channel mutation linked to trigeminal neuralgia

  2023cited by this paper
• CaV3.2 calcium channels contribute to trigeminal neuralgia.

  2022cited by this paper
• Electrophysiological and computational analysis of Cav3.2 channel variants associated with familial trigeminal neuralgia

  2022cited by this paper
• Selective targeting of NaV1.7 via inhibition of the CRMP2-Ubc9 interaction reduces pain in rodents

  2021cited by this paper
• Small molecule targeting NaV1.7 via inhibition of the CRMP2-Ubc9 interaction reduces and prevents pain chronification in a mouse model of oxaliplatin-induced neuropathic pain

  2021cited by this paper
• Non-SUMOylated CRMP2 decreases NaV1.7 currents via the endocytic proteins Numb, Nedd4-2 and Eps15

  2021cited by this paper
• Painful and painless mutations of SCN9A and SCN11A voltage-gated sodium channels

  2020cited by this paper
• [EXPRESS] Trigeminal Neuralgia: an overview from pathophysiology to pharmacological treatments.

  2020cited by this paper
• Exome Sequencing Implicates Impaired GABA Signaling and Neuronal Ion Transport in Trigeminal Neuralgia

  2020cited by this paper
• Mining the Nav1.7 interactome: Opportunities for chronic pain therapeutics.

  2019cited by this paper
• A Comprehensive Review of Trigeminal Neuralgia

  2019cited by this paper
• European Academy of Neurology guideline on trigeminal neuralgia

  2019cited by this paper
• NaV1.7 as a pain target - From gene to pharmacology.

  2017cited by this paper
• A Gain-of-Function Mutation in Nav1.6 in a Case of Trigeminal Neuralgia

  2016cited by this paper
• Hierarchical CRMP2 posttranslational modifications control NaV1.7 function

  2016cited by this paper
• CRMP2 Protein SUMOylation Modulates NaV1.7 Channel Trafficking*

  2013cited by this paper
• Potassium channels as a potential therapeutic target for trigeminal neuropathic and inflammatory pain

  2011cited by this paper
• Mutations in sodium-channel gene SCN9A cause a spectrum of human genetic pain disorders.

  2007cited by this paper

• Ion-channel mRNA expression alterations in a cervical dorsal horn compression induced novel rabbit model of trigeminal neuropathic pain

  2025cites this paper